Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  203.45
-6.66 (-3.17%)
AAPL  267.23
+2.65 (1.00%)
AMD  196.56
-3.59 (-1.79%)
BAC  50.96
-2.10 (-3.96%)
GOOG  314.00
-0.90 (-0.29%)
META  643.28
-12.38 (-1.89%)
MSFT  386.38
-10.85 (-2.73%)
NVDA  190.93
+1.11 (0.58%)
ORCL  139.28
-8.80 (-5.94%)
TSLA  397.15
-14.67 (-3.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.